Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCK-8 Disposition and Efficacy in Healthy Males
NCT02507167Phase 1Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Nov 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of rifampicin (2 arms), sponsored by Universitätsklinikum Greifswald. Primary endpoint: Cholecystokinin-8. Started Nov 2012; status: completed.
02
Drugs
rifampicin
Beyond the preview
Go deeper on NCT02507167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02507167.